Stapokibart: all 36 studies that test it
Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory LymphomaNot yet recruitingNCT07791615Phase 2
- Study on the Treatment of Adolescent Patients With Seasonal Allergic RhinitisRecruitingNCT07678931Phase 3
- Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)Not yet recruitingNCT07617324Phase 2
- Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal PolypsNot yet recruitingNCT07616609Not applicable
- Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia SyndromeNot yet recruitingNCT07240376Not applicable
- Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous PemphigoidNot yet recruitingNCT07210554Phase 3
- Efficacy and Safety of Stapokibart for Primary Cutaneous AmyloidosisNot yet recruitingNCT07143864Not applicable
- A Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT07106372Phase 3
- Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCCRecruitingNCT07040072Phase 1
- Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 3
- A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal PolypsNot yet recruitingNCT06801353Phase 4
- A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT06547333Phase 2/3
- Study of Stapokibart Injection in Patients With Allergic RhinitisRecruitingNCT06525597Phase 2
- Study of CM310 in Subjects With Seasonal Allergic RhinitisNot yet recruitingNCT06171074Phase 2
- Study Evaluating the Pharmacokinetics of CM310 in Healthy SubjectsNot yet recruitingNCT06171048Phase 1
- A Study of CM310 in Subjects With Moderate to Severe AsthmaRecruitingNCT05761028Phase 2/3
- Study of CM310 in Adolescent Subjects With Atopic DermatisActive, not recruitingNCT06495229Phase 3
- Study on the Treatment of Prurigo Nodularis With Stapokibart InjectionCompletedNCT06424470Phase 3
- Study of CM310 Injection in Adolescent Subjects With Atopic DermatisCompletedNCT06277765Phase 3
- Study of CM310 in Children Subjects With Moderate-to-severe Atopic DermatisCompletedNCT06162507Phase 1/2
- Study of CM310 in Healthy SubjectsCompletedNCT06161090Phase 1
- A Study of CM310 in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT06116565Phase 2
- Study of CM310 in Patients With Allergic RhinitisCompletedNCT05908721Phase 2
- Study of CM310 in Subjects With Allergic RhinitisCompletedNCT05908032Phase 3
- Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related DiseaseStatus unknownNCT05728684Not applicable
- Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT05715320Phase 2
- Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310CompletedNCT05702450Phase 1
- A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
- A Study of CM310 in Subjects With Chronic PruritusStatus unknownNCT05452343Phase 2
- A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
- A Study of CM310 in Subjects With Moderate to Severe AsthmaCompletedNCT05186909Phase 2
- The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05131464Phase 2
- Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
- The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
- Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04805411Phase 2
- Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)CompletedNCT04805398Phase 2